Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats

Finding ways to enhance the effectiveness of existing anxiety treatments while potentially reducing their required doses is a valuable therapeutic strategy. This study by Kasian, Kolomin, Andreeva, and colleagues investigated whether Selank could synergistically enhance the anti-anxiety effects of diazepam in rats subjected to unpredictable chronic mild stress.

The researchers used an unpredictable chronic mild stress model to induce anxiety-like behavior in rats, then administered Selank alone, diazepam alone, or both in combination. Behavioral tests were used to measure anxiety levels and determine whether the peptide-drug combination produced effects greater than either treatment alone.

The results showed that Selank synergistically enhances the anti-anxiety effects of diazepam, meaning the combination produces greater anxiety relief than would be expected from simply adding the individual effects together. This synergistic interaction suggests the two compounds work through complementary mechanisms.

For anxiety treatment, this finding has practical clinical implications. The ability of Selank to enhance diazepam's effectiveness could potentially allow for lower doses of the benzodiazepine to achieve the same therapeutic benefit, reducing the risk of side effects and dependency while maintaining or improving treatment outcomes.